|
1
|
Lydiatt WM, Shah JP and Hoffman HTHead
Neck Sites Task Force. American Joint Committee on Cancer: AJCC
stage groupings for head and neck cancer: should we look at
alternatives? A report of the Head and Neck Sites Task Force. Head
Neck. 23:607–612. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osman I, Sherman E, Singh B, et al:
Alteration of p 53 pathway in squamous cell carcinoma of the head
and neck: impact on treatment outcome in patients treated with
larynx preservation intent. J Clin Oncol. 20:2980–2987. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Izzo JG, Papadimitrakopoulou VA, Liu DD,
et al: Cyclin D1 genotype, response to biochemoprevention and
progression rate to upper aerodigestive tract cancer. J Natl Cancer
Inst. 95:198–205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ang KK, Berkey BA, Tu X, et al: Impact of
epidermal growth factor receptor expression on survival and pattern
of relapse in patients with advanced head and neck carcinoma.
Cancer Res. 62:7350–7356. 2002.PubMed/NCBI
|
|
5
|
Rohren EM, Turkington TG and Coleman RE:
Clinical applications of PET in oncology. Radiology. 231:305–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minn H, Clavo AC, Grenman R and Wahl RL:
In vitro comparison of cell proliferation kinetics and uptake of
tritiated fluorodeoxyglucose and L-methionine in squamous-cell
carcinoma of the head and neck. J Nucl Med. 36:252–258.
1995.PubMed/NCBI
|
|
7
|
Haberkorn U, Strauss LG, Reisser C, et al:
Glucose uptake, perfusion, and cell proliferation in head and neck
tumors: relation of positron emission tomography to flow cytometry.
J Nucl Med. 32:1548–1555. 1991.PubMed/NCBI
|
|
8
|
Vansteenkiste JF, Stroobants SG, Dupont
PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA and Demedts
MG: Prognostic importance of the standardized uptake value
on18F-fluoro-2-deoxy-glucose-positron emission tomography scan in
non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung
Cancer Group. J Clin Oncol. 17:3201–3206. 1999.PubMed/NCBI
|
|
9
|
Berghmans T, Dusart M, Paesmans M, et al
European Lung Cancer Working Party for the IASLC Lung Cancer
Staging Project: Primary tumor standardized uptake value (SUVmax)
measured on fluorodeoxyglucose positron emission tomography
(FDG-PET) is of prognostic value for survival in non-small cell
lung cancer (NSCLC): a systematic review and meta-analysis (MA) by
the European Lung Cancer Working Party for the I ASLC Lung Cancer
Staging Project. J Thorac Oncol. 3:6–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brun E, Kjellen E, Tennvall J, et al: FDG
PET studies during treatment: prediction of therapy outcome in head
and neck squamous cell carcinoma. Head Neck. 24:127–135. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allal AS, Slosman DO, Kebdani T, Allaoua
M, Lehmann W and Dulguerov P: Prediction of outcome in
head-and-neck cancer patients using the standardized uptake value
of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys.
59:1295–1300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SY, Roh JL, Kim MR, et al: Use
of18F-FDG PET for primary treatment strategy in patients with
squamous cell carcinoma of the oropharynx. J Nucl Med. 48:752–757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roh JL, Pae KH, Choi SH, et al:
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as
guidance for primary treatment in patients with advanced-stage
resectable squamous cell carcinoma of the larynx and hypopharynx.
Eur J Surg Oncol. 33:790–795. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao CT, Chang JT, Wang HM, et al:
Pretreatment primary tumor SUVmax measured by FDG-PET and
pathologic tumor depth predict for poor outcomes in patients with
oral cavity squamous cell carcinoma and pathologically positive
lymph nodes. Int J Radiat Oncol Biol Phys. 73:764–771. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torizuka T, Tanizaki Y, Kanno T,
Futatsubashi M, Naitou K, Ueda Y and Ouchi Y: Prognostic value
of18F-FDG PET in patients with head and neck squamous cell cancer.
AJR Am J Roentgenol. 192:W156–W160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allal AS, Dulguerov P, Allaoua M,
Haenggeli CA, EI-Ghazi el A, Lehmann W and Slosman DO: Standardized
uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting
outcome in head and neck carcinomas treated by radiotherapy with or
without chemotherapy. J Clin Oncol. 20:1398–1404. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burk D, Woods M and Hunter J: On the
significance of glucolysis for cancer growth, with special
reference to Morris rat hepatomas. J Natl Cancer Inst. 38:839–863.
1967.PubMed/NCBI
|
